Soleil Securities Group initiates coverage on ICU Medical (Nasdaq: ICUI) with a Buy rating and $33 price target, citing valuation.
This article: 125 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE